MoneyWorks4Me

Everest Organics - Quaterly Results

28 May 2025 Evaluate
The sales for the March 2025 quarter moved down to Rs. 409.35 millions as compared to Rs. 526.17 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 4920.69% to Rs. 29.12  millions  from Rs. 0.58 millions in previous same quarter.Operating profit for the quarter ended March 2025 rose to 36.53 millions as compared to 32.57 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 409.35 526.17 -22.20 1594.79 1972.41 -19.15 1594.79 1972.41 -19.15
Other Income 2.16 2.97 -27.27 6.87 8.86 -22.46 6.87 8.86 -22.46
PBIDT 36.53 32.57 12.16 79.10 118.73 -33.38 79.10 118.73 -33.38
Interest 11.47 12.43 -7.72 51.90 54.66 -5.05 51.90 54.66 -5.05
PBDT 25.06 20.14 24.43 27.20 64.07 -57.55 27.20 64.07 -57.55
Depreciation 15.58 18.52 -15.87 59.62 57.96 2.86 59.62 57.96 2.86
PBT 9.48 1.62 485.19 -32.42 6.11 -630.61 -32.42 6.11 -630.61
TAX -19.64 1.04 -1988.46 -19.52 4.71 -514.44 -19.52 4.71 -514.44
Deferred Tax -19.64 0.74 -2754.05 -19.52 3.71 -626.15 -19.52 3.71 -626.15
PAT 29.12 0.58 4920.69 -12.90 1.40 -1021.43 -12.90 1.40 -1021.43
Equity 97.10 80.00 21.37 97.10 80.00 21.37 97.10 80.00 21.37
PBIDTM(%) 8.92 6.19 44.17 4.96 6.02 -17.60 4.96 6.02 -17.60
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..